BGI News More Academic and Education More Research Collaboration More BGI in the news More
Contact Us

Media Contact

Tel: +86-755-36307212

Email: media@genomics.cn 
0
BGI and University of Manchester Sign Agreement to Promote Collaboration in Synthetic Biology and Metabolic Engineering
Publish Date: 2017-11-10

SHENZHEN, China Nov. 9, 2017 -- At the 12th annual International Conference on Genomics (ICG-12) held in China National GeneBank (CNGB), BGI and the University of Manchester signed a strategic cooperation agreement to promote collaboration in synthetic biology and metabolic engineering.

Dr. Yizhi Cai, Chair in Synthetic Genomics at the University of Manchester, and Dr. Xun Xu, Director of BGI-Research and Executive Director of CNGB, signed a Memorandum of Understanding Oct. 28 to promote strategic collaboration. Dr. Huanming Yang, Chairman of BGI; Dr. Hank Wang, CBO of BGI; Dr. Yue Shen, Director of Genome Synthesis and Editing Platform of CNGB; and Jason Chen, Head of International Cooperation at CNGB, witnessed the signing ceremony. Both parties agreed on a five-year collaboration in the areas of synthetic biology and metabolic engineering of natural products, to promote academic research, education and industrialization.

In recent years, China has witnessed booming development in synthetic biology and metabolic engineering, which provides profitable opportunities in a wide range of areas including bio-manufacturing, pharmacology, energy, environment and agriculture. This March, the ground-breaking achievement of BGI-Research/CNGB in the international Synthetic Yeast Genome Project 2.0Sc2.0 Projectshows huge potential in applying synthetic biology to address current medical and environmental issues. In response to the immediate call for its industrialization, this agreement represents a model of collaboration between academe and industry. The agreement aims to help both parties fully leverage each other’s resources, so that individuals working in this field better achieve their potential and industries gain more opportunities to commercialize their research projects.

Prof. Cai has been working in the frontier of synthetic biology and metabolic engineering for many years. Encouraged by the growth of synthetic biology in China, he worked tirelessly to initiate this collaboration. At the signing ceremony, he emphasized the importance of genome modification associated with medicine, energy, environment and other fields. “We are glad to cooperate with BGI. We expect close collaboration with BGI in synthetic biology,” he said.

Prof. Yang praised this collaboration. “We are faced with both challenges and opportunities in the rising tide of synthetic biology,” he said. “We should encourage multi-party collaboration to overcome obstacles and discover new potentials.”

Dr. Xu remarked that synthetic biology and metabolic engineering show huge potential in bio-manufacturing. For example, natural products like artemisinin have generated tremendous value in improving people’s health but there are still considerable issues to be resolved.  This collaboration aims to bring the best of both sides together to help overcome technical bottlenecks as well as foster professional development in this field.

Jason Chen, Head of International Cooperation at CNGB, remarked that BGI-Research and The University of Manchester have long been closely connected, and this agreement further promotes exchange of experience and expertise from both parties. At the forefront of this collaboration is the “Guangdong High-throughput Genome Sequencing-Synthesis-Editing Key Laboratory” of National GeneBank of Shenzhen who values this opportunity to enlarge its international influence, as well as initiate technology innovation in China and the U.K.

About BGI-Research

BGI-Research is a non-profit organization devoted to life science, biotechnology and transomics innovation in applied medicine to promote development of future agriculture and future health. As of July 2017, researchers from BGI have generated more than 2211 publications (1746 SCI articles) and more than 2000 peer reviews, 314 of which are published in GigaScience, Cell, Nature, New England Journal of  Medicine, or Science, which have been cited 108,347 times; 13 software copyrights and more than 100 patents have been registered.

About The University of Manchester

The University of Manchester is the UK’s largest single-site university with 38,600 students and is consistently ranked among the world’s elite for graduate employability.  The University is also one of the country’s major research institutions, rated fifth in the UK in terms of ‘research power’ (REF 2014). World class research is carried out across a diverse range of fields including cancer, advanced materials, addressing global inequalities, energy and industrial biotechnology.

No fewer than 25 Nobel laureates have either worked or studied here.

Manchester is ranked 35th in the world in the Academic Ranking of World Universities 2016 and 5th in the UK. The University had an annual income of almost £1 billion in 2015/16.

Visit www.manchester.ac.uk for further information.

Facts and figures: http://www.manchester.ac.uk/discover/facts-figures/

Research Beacons: http://www.manchester.ac.uk/research/beacons/

Addressing global inequalities

Addressing global inequalities is one of The University of Manchester’s research beacons - examples of pioneering discoveries, interdisciplinary collaboration and cross-sector partnerships that are tackling some of the biggest questions facing the planet. #ResearchBeacons

[Addressing global inequalities video]

Advanced materials

Advanced materials is one of The University of Manchester’s research beacons - examples of pioneering discoveries, interdisciplinary collaboration and cross-sector partnerships that are tackling some of the biggest questions facing the planet. #ResearchBeacons

[Advanced materials video]

Cancer

Cancer is one of The University of Manchester’s research beacons - examples of pioneering discoveries, interdisciplinary collaboration and cross-sector partnerships that are tackling some of the biggest questions facing the planet. #ResearchBeacons

[Cancer video]

Energy

Energy is one of The University of Manchester’s research beacons - examples of pioneering discoveries, interdisciplinary collaboration and cross-sector partnerships that are tackling some of the biggest questions facing the planet. #ResearchBeacons

[Energy video]

Industrial biotechnology

Industrial biotechnology is one of The University of Manchester’s research beacons - examples of pioneering discoveries, interdisciplinary collaboration and cross-sector partnerships that are tackling some of the biggest questions facing the planet. #ResearchBeacons

[Industrial biotechnology video]